Prevalence of multi-drug resistant bacteria in intensive care units at Tripoli University Hospital, Tripoli, Libya

References

• Rana MM, Grossi P, Huprikar S. Multidrug-resistant organisms in Solid Organ Transplantation. In: Manuel O Ison M, editors. Infectious diseases in Solid-Organ transplant recipients: a practical approach [internet]. Cham: Springer International Publishing; 2019 [cited 2024 Apr 8]. p. 145–8. doi: 10.1007/978-3-030-15394-6_11
   Google Scholar
• Hutchings MI, Truman AW, Wilkinson B. Antibiotics: past, present and future. Curr Opin Microbiol. 2019;51:72–80. doi: 10.1016/j.mib.2019.10.008
   PubMed Web of Science ®Google Scholar
• Khan AA, Manzoor KN, Sultan A, et al. Pulling the Brakes on Fast and furious multiple drug-resistant (MDR) bacteria. Int J Mol Sci [Internet]. 2021 cited 2024 Apr 8;22(2):859. doi: 10.3390/ijms22020859
   PubMed Web of Science ®Google Scholar
• CDC. The biggest antibiotic-resistant threats in the U.S. [internet]. Centers for Disease Control and Prevention. 2022 [cited 2024 Apr 8]. Available from: https://www.cdc.gov/drugresistance/biggest-threats.html
   Google Scholar
• Uchil RR, Kohli GS, Katekhaye VM, et al. Strategies to combat antimicrobial resistance. J Clin Diagn Res [Internet]. 2014 [cited 2024 Apr 8];8:ME01–ME04. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149102/
   PubMedGoogle Scholar
• Rizvi SG, Ahammad SZ. COVID-19 and antimicrobial resistance: a cross-study. Sci Total Environ [Internet]. 2022 [cited 2024 Apr 8];807:150873. Available from: https://www.sciencedirect.com/science/article/pii/S0048969721059519
   PubMed Web of Science ®Google Scholar
• Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–327. doi: 10.1016/S1473-3099(17)30753-3
   PubMed Web of Science ®Google Scholar
• Al-Said H, Alghamdi A, Ashgar S, et al. Isolation and detection of drug-resistant bacterial pathogens in postoperative wound infections at a tertiary care hospital in Saudi Arabia. Saudi j med med sci [Internet]. 2023 cited 2024 Apr 9;11(3):229. Available from: https://pubmed.ncbi.nlm.nih.gov/37533663/
   PubMed Web of Science ®Google Scholar
• Russotto V, Cortegiani A, Fasciana T, et al. What healthcare workers should know about environmental bacterial contamination in the intensive care unit. Biomed Res Int. 2017;2017:1–7. doi: 10.1155/2017/6905450
   Web of Science ®Google Scholar
• El Salabi A, Borra PS, Toleman MA, et al. Genetic and biochemical characterization of a novel metallo-β-lactamase, TMB-1, from an Achromobacter xylosoxidans strain isolated in Tripoli, Libya. Antimicrob Agents Chemother [Internet]. 2012 [cited 2024 Apr 9];56(5):2241–2245. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3346670/
   PubMed Web of Science ®Google Scholar
• Mathlouthi N, Areig Z, Al Bayssari C, et al. Emergence of carbapenem-resistant Pseudomonas aeruginosa and acinetobacter baumannii clinical isolates collected from some Libyan hospitals. Microb Drug Resist. 2015;21(3):335–341. doi: 10.1089/mdr.2014.0235
   PubMed Web of Science ®Google Scholar
• Mathlouthi N, El Salabi AA, Ben Jomàa-Jemili M, et al. Early detection of metallo-β-lactamase NDM-1- and OXA-23 carbapenemase-producing acinetobacter baumannii in Libyan hospitals. Int J Antimicrob Agents. 2016;48(1):46–50. doi: 10.1016/j.ijantimicag.2016.03.007
   PubMed Web of Science ®Google Scholar
• Mathlouthi N, Al-Bayssari C, El Salabi A, et al. Carbapenemases and extended-spectrum β-lactamases producing enterobacteriaceae isolated from Tunisian and Libyan hospitals. J Infect Dev Ctries. 2016;10(7):718–727. doi: 10.3855/jidc.7426
   PubMed Web of Science ®Google Scholar
• Slimene K, Ali AA, Mohamed EA, et al. Isolation of carbapenem and colistin resistant gram-negative bacteria colonizing immunocompromised SARS-CoV-2 patients admitted to some Libyan hospitals. Microbiol Spectr [Internet]. 2023 [cited 2024 Apr 9];11(3):e02972–22. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269485/
   PubMed Web of Science ®Google Scholar
• Alrbee AA, Elzen A, Salabi AAE. Isolation of multi-drug resistant gram-negative bacteria producing extended spectrum beta lactamases in operating theaters of sebha medical center, Sebha, Libya. JOPAS [Internet]. 2019 [cited 2024 Apr 9];18. Available from: https://sebhau.edu.ly/journal/jopas/article/view/313
   Google Scholar
• Alrbee AA, Elzen A, Salabi AAE. Detection of multi-drugs resistant gram-negative bacilli bacteria producing metallo beta lactamases in intensive care unit of sebha medical center, Sebha, Libya. JOPAS [Internet]. 2022 [cited 2024 Apr 9];21:261–269. Available from: https://sebhau.edu.ly/journal/jopas/article/view/2205
   Google Scholar
• Galvin S, Dolan A, Cahill O, et al. Microbial monitoring of the hospital environment: why and how? J Hosp Infect. 2012;82(3):143–151. doi: 10.1016/j.jhin.2012.06.015
   PubMed Web of Science ®Google Scholar
• Elsorady KE, Hassan RA, Abdelhamid DH, et al. Antibiotics use and its association with multi-drug resistance in a tertiary care geriatrics hospital in Egypt. J Infect Dev Ctries. 2022;16(12):1860–1869. doi: 10.3855/jidc.17257
   PubMed Web of Science ®Google Scholar
• Hassan MA, Abd El-Aziz S, Elbadry HM, et al. Prevalence, antimicrobial resistance profile, and characterization of multi-drug resistant bacteria from various infected wounds in North Egypt. Saudi J Biol Sci. 2022;29(4):2978–2988. doi: 10.1016/j.sjbs.2022.01.015
   PubMed Web of Science ®Google Scholar
• Abdelkader MM, Aboshanab KM, El-Ashry MA, et al. Prevalence of MDR pathogens of bacterial meningitis in Egypt and new synergistic antibiotic combinations. PLOS ONE. 2017;12(2):e0171349. doi: 10.1371/journal.pone.0171349
   PubMed Web of Science ®Google Scholar
• Osman EA, Yokoyama M, Altayb HN, et al. Klebsiella pneumonia in Sudan: multidrug resistance, polyclonal dissemination, and virulence. Antibiotics. 2023;12(2):233. doi: 10.3390/antibiotics12020233
   Google Scholar
• Moglad EH. Antibiotics profile, prevalence of extended-spectrum beta-lactamase (ESBL), and multidrug-resistant enterobacteriaceae from different clinical samples in Khartoum State, Sudan. Int J Microbiol. 2020;2020:8898430. doi: 10.1155/2020/8898430
   PubMed Web of Science ®Google Scholar
• Hussain MA, Mohamed MS, Altayb HN, et al. Comparative genomic analysis of multi-drug resistant Pseudomonas aeruginosa sequence type 235 isolated from Sudan. Microorganisms. 2023;11(6):1432. doi: 10.3390/microorganisms11061432
   PubMed Web of Science ®Google Scholar
• Siddig LA, Bayoumi M, Elhadi N. Sociodemographic distributions and molecular characterization of colonized Enterococcus faecium isolates from locality hospitals in Khartoum, Sudan. PeerJ. 2023;11:e16169. doi: 10.7717/peerj.16169
   PubMed Web of Science ®Google Scholar
• Moglad EH, Altayb HN. Antibiogram, prevalence of methicillin-resistant and multi-drug resistant staphylococcus spp. In different clinical samples. Saudi J Biol Sci. 2022;29(12):103432. doi: 10.1016/j.sjbs.2022.103432
   PubMed Web of Science ®Google Scholar
• Frigui S, Bourbiaa Y, Mokline A, et al. Nosocomial bacteremia in burns: clinical and bacterial epidemiology. Ann Burns Fire Disasters. 2021;34(1):10–17.
   PubMedGoogle Scholar
• Tfifha M, Ferjani A, Mallouli M, et al. Carriage of multidrug-resistant bacteria among pediatric patients before and during their hospitalization in a tertiary pediatric unit in Tunisia. Libyan J Med. 2018;13(1):1419047. doi: 10.1080/19932820.2017.1419047
   PubMedGoogle Scholar
• Elramalli A, Almshawt N, Ahmed MO. Current problematic and emergence of carbapenemase-producing bacteria: a brief report from a Libyan hospital. Pan Afr Med J. 2017;26:180. doi: 10.11604/pamj.2017.26.180.9637
   PubMedGoogle Scholar
• Zorgani A, Almagatef A, Sufya N, et al. Detection of CTX-M-15 among uropathogenic Escherichia coli isolated from five Major hospitals in Tripoli, Libya. Oman Med J. 2017;32(4):322–327. doi: 10.5001/omj.2017.61
   PubMedGoogle Scholar
• Abujnah AA, Zorgani A, Sabri MAM, et al. Multidrug resistance and extended-spectrum β-lactamases genes among Escherichia coli from patients with urinary tract infections in Northwestern Libya. Libyan J Med. 2015;10(1):26412. doi: 10.3402/ljm.v10.26412
   PubMedGoogle Scholar
• Salabi AAE. Characterisation of antibiotic resistance mechanisms in Gram-negative bacteria from Tripoli and Benghazi, Libya [internet]. Published by ProQuest LLC 2013; 2011 [cited 2024 Apr 9]. Available from: https://orca.cardiff.ac.uk/id/eprint/55122/1/U585511.pdf
   Google Scholar
• Bhandari P, Thapa G, Pokhrel BM, et al. Nosocomial isolates and their drug resistant pattern in ICU patients at national institute of neurological and allied sciences, Nepal. Int. J. Microbiol. [Internet] 2015 [cited 2024 Apr 9];2015:1–6. Available from: http://www.hindawi.com/journals/ijmicro/2015/572163/
   Google Scholar
• Patwardhan RB, Dhakephalkar PK, Niphadkar KB, et al. A study on nosocomial pathogens in ICU with special reference to multiresistant acinetobacter baumannii harbouring multiple plasmids. Indian J Med Res. 2008;128:178–187.
   PubMed Web of Science ®Google Scholar
• Radji M, Fauziah S, Aribinuko N. Antibiotic sensitivity pattern of bacterial pathogens in the intensive care unit of Fatmawati Hospital, Indonesia. Asian Pac J Trop Biomed. 2011;1(1):39–42. doi: 10.1016/S2221-1691(11)60065-8
   PubMedGoogle Scholar
• Mythri H, Kashinath K. Nosocomial infections in patients admitted in intensive care unit of a tertiary health center, India. Ann Med Health Sci Res. 2014;4(5):738–741. doi: 10.4103/2141-9248.141540
   PubMedGoogle Scholar
• Vincent J-L, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323–2329. doi: 10.1001/jama.2009.1754
   PubMed Web of Science ®Google Scholar
• Torres DA, Seth-Smith HMB, Joosse N, et al. Colistin resistance in Gram-negative bacteria analysed by five phenotypic assays and inference of the underlying genomic mechanisms. BMC Microbiology [Internet]. 2021 [cited 2024 Apr 8];21(1):321. Available from. doi: 10.1186/s12866-021-02388-8
   PubMed Web of Science ®Google Scholar
• Olaitan AO, Morand S, Rolain J-M. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol [Internet]. 2014 [cited 2024 Apr 9];5. Available from: https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2014.00643/full
   PubMed Web of Science ®Google Scholar
• Paterson DL, Harris PNA. Colistin resistance: a major breach in our last line of defence. Lancet Infect Dis [Internet]. 2016 [cited 2024 Apr 12];16(2):132–133. Available from: https://www.sciencedirect.com/science/article/pii/S1473309915004636
   PubMed Web of Science ®Google Scholar
• Chew KL, La M-V, Lin RTP, et al. Colistin and polymyxin B susceptibility testing for carbapenem-resistant and mcr-Positive Enterobacteriaceae: comparison of sensititre, MicroScan, Vitek 2, and etest with broth microdilution. J Clin Microbiol. 2017;55(9):2609–2616. doi: 10.1128/JCM.00268-17
   PubMed Web of Science ®Google Scholar
• Scaglione V, Reale M, Davoli C, et al. Prevalence of antibiotic resistance over time in a third-level university hospital. Microbial Drug Resist [Internet]. 2022 [cited 2024 Apr 9];28(4):425–435. Available from: https://www.liebertpub.com/doi/10.1089/mdr.2021.0109
   PubMed Web of Science ®Google Scholar
• Cerini P, Meduri FR, Tomassetti F, et al. Trends in antibiotic resistance of nosocomial and community-acquired infections in Italy. Antibiotics. 2023;12(4):651. doi: 10.3390/antibiotics12040651
   Google Scholar